1h Free Analyst Time
The testosterone replacement therapy market is forecasted to grow by USD 461 million during 2024-2029, accelerating at a CAGR of 3.3% during the forecast period. The report on the testosterone replacement therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising initiatives to increase awareness about hypogonadism among people, rise in prevalence of chronic diseases, and increasing aging population and postmenopausal women.
The testosterone replacement therapy market is segmented as below:
By Distribution Channel
- Hospitals
- Retail
- Online
By Product
- Injectables
- Topicals
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the testosterone replacement therapy market covers the following areas:
- Testosterone Replacement Therapy Market sizing
- Testosterone Replacement Therapy Market forecast
- Testosterone Replacement Therapy Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Distribution Channel
9 Market Segmentation by Product
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global testosterone replacement therapy market: AbbVie Inc., Acerus Pharmaceuticals Corp., Acrux Ltd., Actiza Pharmaceutical Pvt. Ltd., Alembic Pharmaceuticals Ltd., Alvogen Inc, Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, Cipla Inc., Eli Lilly and Co., Endo International Plc, Ferring BV, Halozyme Therapeutics Inc., Insud Pharma S.L, Lupin Ltd., Marius Pharmaceuticals, Pfizer Inc., Sawai Group Holdings Co. Ltd., and Teva Pharmaceutical Industries Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rise in novel therapeutic approaches for testosterone replacement therapy."
According to the report, one of the major drivers for this market is the rising initiatives to increase awareness about hypogonadism among people.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Acerus Pharmaceuticals Corp.
- Acrux Ltd.
- Actiza Pharmaceutical Pvt. Ltd.
- Alembic Pharmaceuticals Ltd.
- Alvogen Inc
- Amneal Pharmaceuticals Inc.
- Bausch Health Companies Inc.
- Bayer AG
- Cipla Inc.
- Eli Lilly and Co.
- Endo International Plc
- Ferring BV
- Halozyme Therapeutics Inc.
- Insud Pharma S.L
- Lupin Ltd.
- Marius Pharmaceuticals
- Pfizer Inc.
- Sawai Group Holdings Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
